药物传输市场规模、份额和成长分析：按类型、技术、应用、设施和地区 - 2025-2032 年行业预测

2023年给药市场规模估值为200.2亿美元，从2024年的217亿美元增长到2032年的413.8亿美元，预计在预测期内（2025-2032年）将以8.4%的复合年增长率增长。

在对有效和有针对性的药物管理的需求的推动下，全球药物传输市场正在不断发展。慢性疾病通常需要持续用药，因此药物传递的精确性至关重要。各种系统，包括植入式设备、注射器和吸入器，正在提高给药准确性和患者依从性。向非侵入性和微创药物替代品的重大转变，导致了经皮吸收贴片、口服给药溶液和滴鼻剂等创新。此外，技术进步和对个人化医疗的日益重视正在推动市场成长。数位健康技术和智慧传输系统的引入实现了即时监测、剂量调整和量身定制的治疗计划，为该领域创造了新的商机。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 生态系绘图
• 市场吸引力指数（2024）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析
• 案例研究
• 技术评估
• 监管环境
• 客户和购买标准分析
• 管道分析
• 疾病流行病学
• Start-Ups分析
• 专利分析

药物输送市场规模：按类型

• 市场概况
• 吸入给药
• 输注药物输送
  • 传统注射装置
  • 自註射器
• 口服给药
  • 固态口服药物
  • 液体口服药物
  • 半固态口服药物
• 局部给药
  • 半固态外用製剂
  • 液体外用製剂
  • 固态外用
  • 经皮局部
• 肺部药物输送
  • 定量吸入器
  • 干粉吸入器
  • 喷雾器
• 鼻腔给药
  • 鼻喷剂
  • 滴鼻剂
  • 鼻凝胶
  • 滴鼻剂
• 粘膜给药
  • 口腔粘膜製剂
  • 口腔给药
  • 其他的
• 植入式药物输送
  • 被动植入药物输送
  • 主动植入药物输送
• 经经皮给药
• 其他的

药物输送市场规模：依技术划分

• 市场概况
• 无针注射器
• 药物输送贴片
• 自动注射器
• 其他的

药物输送市场规模：依应用分类

• 市场概况
• 癌症
• 感染疾病
• 肿瘤学
• 糖尿病
• 心血管疾病
• 呼吸系统疾病
• 中枢神经系统疾病
• 中枢神经系统疾病
• 自体免疫疾病
• 其他的

药物输送市场规模：依使用设施划分

• 市场概况
• 医院
• 门诊手术中心
• 家庭护理设置
• 诊断中心
• 其他的

药物传输市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Johnson & Johnson
• Pfizer Inc.
• Novartis International AG
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Sanofi
• AstraZeneca plc
• Roche Holding AG
• Eli Lilly and Company
• Bayer AG
• Bristol-Myers Squibb Company
• AbbVie Inc.
• Amgen Inc.
• Novo Nordisk A/S
• Gilead Sciences, Inc.
• Takeda Pharmaceutical Company Limited
• Biogen Inc.
• Astellas Pharma Inc.
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Company, Limited

结论和建议

Drug Delivery Market size was valued at USD 20.02 Billion in 2023 and is poised to grow from USD 21.7 Billion in 2024 to USD 41.38 Billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global drug delivery market is evolving, driven by the demand for effective, targeted pharmaceutical administration. As chronic diseases often require ongoing medication, precision in drug delivery is paramount. Various systems, including implantable devices, injectables, and inhalers, enhance dosing accuracy and patient adherence. There is a noticeable shift towards non-invasive and minimally invasive alternatives, leading to innovations like transdermal patches, oral delivery solutions, and nasal sprays. Additionally, technological advancements and the increasing emphasis on personalized medicine are propelling market growth. The incorporation of digital health technologies and smart delivery systems is further enhancing the landscape, enabling real-time monitoring, dose adjustments, and tailored treatment plans, thus creating new opportunities within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Drug Delivery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Drug Delivery Market Segmental Analysis

Global Drug Delivery Market is segmented by type, technique, application, facility of use and region. Based on type, the market is segmented into inhalation drug delivery, injectable drug delivery, oral drug delivery, topical drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, implantable drug delivery, transdermal drug delivery and others. Based on technique, the market is segmented into needle-free injectors, drug delivery patches, autoinjectors and others. Based on application, the market is segmented into cancer, infectious diseases, oncology, diabetes, cardiovascular diseases, respiratory diseases, central nervous system disorders, CNS disorders, autoimmune diseases and others. Based on facility of use, the market is segmented into hospitals, ambulatory surgery centers, home care settings, diagnostic centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Drug Delivery Market

The global drug delivery market is experiencing significant growth driven by the rising demand for self-administration and home healthcare solutions. Patients are increasingly prioritizing convenience and autonomy in managing their treatment regimens. As a result, the market has seen the emergence of user-friendly and portable drug delivery devices, including autoinjectors, inhalers, and insulin pens, designed to facilitate at-home medication administration. These innovative devices not only empower patients by enabling them to self-manage their therapies but also minimize the frequency of hospital visits, thereby enhancing overall patient satisfaction and comfort in their healthcare journeys.

Restraints in the Drug Delivery Market

The drug delivery market faces notable restraints primarily due to the high costs associated with the development and manufacturing of sophisticated delivery systems. The expenses are amplified by comprehensive research and development initiatives, thorough clinical trials, intricate manufacturing protocols, and strict quality control requirements. Such financial burdens can hinder the broader implementation of these advanced technologies, especially in resource-constrained healthcare environments. Consequently, issues of affordability and cost-effectiveness emerge as critical factors that influence the accessibility and utilization of cutting-edge drug delivery solutions, thereby impacting their integration into mainstream medical practice.

Market Trends of the Drug Delivery Market

The Drug Delivery market is witnessing a significant trend towards targeted drug delivery systems, which focus on administering medications directly to specific sites within the body. This precision not only heightens treatment efficacy but also minimizes systemic side effects, making it increasingly favorable for managing complex diseases like cancer, autoimmune disorders, and chronic conditions. Innovations such as nanoparticles, liposomes, micelles, and implantable devices are at the forefront of this shift, enhancing drug efficacy and reducing dosage requirements. Additionally, targeted systems improve patient compliance and mitigate off-target effects, positioning them as a crucial component in the future of therapeutic strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree Of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2024
• Pestel Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology
• Startup Analysis
• Patent Analysis

Global Drug Delivery Market Size by Type & CAGR (2025-2032)

• Market Overview
• Inhalation Drug Delivery
• Injectable Drug Delivery
  • Conventional Injection Devices
  • Self-Injection Devices
• Oral Drug Delivery
  • Solid Oral Drugs
  • Liquid Oral Drugs
  • Semi Solid Oral Drugs
• Topical Drug Delivery
  • Semi Solid Topical
  • Liquid Topical
  • Solid Topical
  • Transdermal Topical
• Pulmonary Drug Delivery
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Nebulizers
• Nasal Drug Delivery
  • Nasal Sprays
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
• Transmucosal Drug Delivery
  • Oral Transmucosal Formulations
  • Buccal Drug Delivery
  • Others
• Implantable Drug Delivery
  • Passive Implantable Drug Delivery
  • Active Implantable Drug Delivery
• Transdermal Drug Delivery
• Others

Global Drug Delivery Market Size by Technique & CAGR (2025-2032)

• Market Overview
• Needle-Free Injectors
• Drug Delivery Patches
• Autoinjectors
• Others

Global Drug Delivery Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cancer
• Infectious Diseases
• Oncology
• Diabetes
• Cardiovascular Diseases
• Respiratory Diseases
• Central Nervous System Disorders
• CNS Disorders
• Autoimmune Diseases
• Others

Global Drug Delivery Market Size by Facility of Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Diagnostic Centers
• Others

Global Drug Delivery Market Size & CAGR (2025-2032)

• North America (Type, Technique, Application, Facility of Use)
  • USA
  • Canada
• Europe (Type, Technique, Application, Facility of Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technique, Application, Facility of Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technique, Application, Facility of Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technique, Application, Facility of Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations